# the Hypertrophic Scar Prevention of BMT101.

> **NCT04012099** · PHASE2 · TERMINATED · sponsor: **Hugel** · enrollment: 20 (actual)

## Conditions studied

- Hypertrophic Scar

## Interventions

- **DRUG:** BMT101

## Key facts

- **NCT ID:** NCT04012099
- **Lead sponsor:** Hugel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-21
- **Primary completion:** 2023-05-10
- **Final completion:** 2023-05-10
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Internal reasons
- **Last updated:** 2023-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04012099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04012099, "the Hypertrophic Scar Prevention of BMT101.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04012099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*